Hilden, North Rhine-Westphalia, Germany
As part of UCB’s sustained and strategic commitment to patients, UCB will continue to focus on fact-based decision making. To enable this, regional Insights-to-Impact (i2i) functions have been established within the corporate development & finance function, which are acting as independent sparring partner to the go-to-market Patient Value units providing Insights for performance understanding & management and resource allocation recommendations, while performing business planning.
Leitung des Commercial und Medical Innen- und Außendienstteams mit der Zielgruppe Neurologen/Epileptologen mit dem Schwerpunkt Epilepsie und seltene Epilepsiesyndrome
Maximize the G2M in Epilepsy, integrate Zogenix with Fintepla and prepare the RARE EPI skills and execute the strategy
Specialists in the Therapeutic Area of CNS and Gastrointestinal Diseases at Eisai GmbH, Coaching of 3 Colleagues and responsible for regional skill training
Medical fieldforce focused on Infectiology/ Oncology